Related Experiment Video
Updated: Dec 1, 2025

Markerless Gene Deletion by Floxed Cassette Allelic Exchange Mutagenesis in Chlamydia trachomatis
Published on: January 30, 2020
Chlamydia trachomatis - the agent
Roberto Cevenini1, Manuela Donati, Vittorio Sambri
1Sezione di Microbiologia, DMCSS, University of Bologna, Policlinico S. Orsola, Via Massarenti 9, 40138, Bologna, Italy.
Abstract:
Chlamydiae are obligate intracellular bacteria, parasitizing eukaryotic cells. Chlamydia trachomatis, C. psittaci and C. pneumoniae are the three species of chlamydiae pathogenic to humans. C. trachomatis shows a tropism for the genital and conjunctival epithelia and consists of 19 different serovars which are pathogenic predominantly for the urogenital tract.A distinguishing feature of chlamydiae is their transition between the infectious elementary body that enters the host cell and the non-infectious reticulate body that replicates intracellularly within an inclusion that does not fuse with lysosomes. Chlamydiae depend for some functions upon the host cell; in particular, chlamydiae have little capacity for generating energy. The complete sequence of the 1000-kb chromosome of C. trachomatis is known, as are most of the genes located on the 7.5-kb cryptic plasmid. Recently, several concepts about the biology and the metabolic pathways of C. trachomatis have been revised in relation to the genome sequence, and different novel proteins have been described.
Insights
Chlamydiae are obligate intracellular bacteria. Research on Chlamydia trachomatis, including its genome, reveals new insights into its biology and metabolic pathways.
Area of Science:
- Microbiology
- Bacteriology
- Infectious Diseases
Background:
- Chlamydiae are obligate intracellular bacteria that infect eukaryotic cells.
- Human pathogenic species include Chlamydia trachomatis, C. psittaci, and C. pneumoniae.
- Chlamydia trachomatis targets genital and conjunctival epithelia, with 19 serovars primarily causing urogenital tract infections.
Purpose of the Study:
- To revise current understanding of Chlamydia trachomatis biology and metabolic pathways.
- To identify novel proteins associated with Chlamydia trachomatis.
Main Methods:
- Analysis of the complete 1000-kb chromosome sequence of C. trachomatis.
- Investigation of genes on the 7.5-kb cryptic plasmid.
- Genomic analysis to revise biological concepts and metabolic pathways.
Main Results:
- The complete genome sequence of C. trachomatis has been elucidated.
- Novel proteins and revised metabolic pathways have been identified.
- Understanding of chlamydial biology has been advanced through genomic insights.
Conclusions:
- Genome sequencing has significantly advanced our knowledge of Chlamydia trachomatis.
- New biological concepts and metabolic pathways are now recognized.
- Further research into novel proteins may reveal new therapeutic targets.
Related Concept Videos
Bacterial Phylum Chlamydiae
Urinary Tract Infection II: Pathophysiology
Fungal Phylum Microsporidia
Bacterial Phylum Tenericutes
Bacterial Phylum Spirochaetes
Sexually Transmitted Infections

